BioLineRx Ltd. (BLRX) Ownership
BLRX ownership summary
as of October 17, 2026- Institutions
- 1.3% of shares outstanding
- Insiders
- 3.43% of shares outstanding
- Shares outstanding
- 5.0M
- Float
- 4.1M shares available to trade
- Short interest
- 2.93% 146K shares short
- Days to cover
- 5.30 short interest down 0.2% vs prior month
- Institutions 1.34%
- Insiders 3.43%
- Other investors 95.23%
BLRX top institutional holders
17 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP | 0.62% | 31K | $62,131 | +30,911 (0.0%) | June 30, 2026 |
| 2 | Renaissance Technologies Corp | 0.31% | 15K | $30,978 | +15,412 (0.0%) | June 30, 2026 |
| 3 | Citadel Advisors Llc | 0.30% | 15K | $29,740 | +14,796 (0.0%) | June 30, 2026 |
| 4 | Rhumbline Advisers | 0.05% | 2,478 | $4,981 | +125 (+5.3%) | June 30, 2026 |
| 5 | Wells Fargo & Co | 0.04% | 2,000 | $4,020 | +250 (+14.3%) | June 30, 2026 |
| 6 | BNP Paribas Arbitrage, SA | 0.01% | 500 | $1,005 | −1,300 (−72.2%) | June 30, 2026 |
| 7 | Banque Cantonale Vaudoise | 0.01% | 321 | $645 | +321 (0.0%) | June 30, 2026 |
| 8 | UBS Group AG | <0.01% | 101 | $203 | −428 (−80.9%) | June 30, 2026 |
| 9 | Goss Wealth Management LLC | <0.01% | 82 | $165 | −25 (−23.4%) | June 30, 2026 |
| 10 | Advisor Group Holdings, Inc. | <0.01% | 26 | $52 | — | June 30, 2026 |
| 11 | SBI Securities Co Ltd | <0.01% | 10 | $20 | +10 (0.0%) | June 30, 2026 |
| 12 | Danske Bank A/S. | 0.00% | 2 | $4 | — | June 30, 2026 |
| 13 | Citigroup Inc | 0.00% | 1 | $2 | −1,727 (−99.9%) | June 30, 2026 |
| 14 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −100 (−100.0%) | June 30, 2026 |
| 15 | Rockefeller Capital Management L.P. | 0.00% | — | — | −12 (−100.0%) | June 30, 2026 |
| 16 | XTX Topco Ltd | 0.00% | — | — | −10,941 (−100.0%) | June 30, 2026 |
| 17 | Bank of America Corp | 0.00% | — | — | −10 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 17, 7 holders added 62K shares and 8 cut 15K.
BLRX top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.04% | 999 | $2,008 | — | March 31, 2025 |
Funds report holdings monthly or quarterly; dates differ by fund.
BLRX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns BLRX
Institutional investors own 1.3% of BioLineRx's shares and insiders 3.43%. The largest holder is Susquehanna International Group, LLP with 0.62% of the shares (31K), as of June 30, 2026. Among the top 17 institutions, 7 added shares and 8 reduced their stake in the latest filings. Short interest is 2.93% of the float, or 5.30 days of average trading volume. The share count rose 7,943.3% since 2014.
Related: BLRX analyst forecast, BLRX key metrics. See the BLRX stock overview for the latest quote and news.
BLRX ownership FAQ
Who owns the most BioLineRx stock?
The largest shareholders of BioLineRx are Susquehanna International Group, LLP (0.62%), Renaissance Technologies Corp (0.31%), Citadel Advisors Llc (0.30%), Rhumbline Advisers (0.05%), Wells Fargo & Co (0.04%).
What percentage of BioLineRx is owned by institutions?
Institutions hold 1.3% of BioLineRx's shares outstanding; insiders hold 3.43%.
Which funds own BioLineRx?
The largest fund holders of BioLineRx are Fidelity Nasdaq Composite Index (0.04%).
What is BioLineRx's short interest?
146K shares of BioLineRx were sold short, 2.93% of the float; at the average daily volume it would take 5.30 days to cover.
How many shares of BioLineRx are outstanding?
BioLineRx has 5.0M shares outstanding, of which 4.1M are in the public float.